tradingkey.logo


tradingkey.logo


Privia Health Group Inc

PRVA
20.020USD
-0.160-0.79%
āļ›āļīāļ” 03/27, 16:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
2.41BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
115.97P/E TTM


āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Privia Health Group Inc āļšāļĢāļīāļĐāļąāļ—

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.

āļ‚āđ‰āļ­āļĄāļđāļĨ Privia Health Group Inc


āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™PRVA
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Privia Health Group Inc
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļApr 29, 2021
āļ‹āļĩāļ­āļĩāđ‚āļ­Mehrotra (Parth)
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™1140
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Apr 29
āļ—āļĩāđˆāļ­āļĒāļđāđˆ950 N. Glebe Rd., Suite 700
āđ€āļĄāļ·āļ­āļ‡ARLINGTON
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ OMX - NASDAQ BASIC
āļ›āļĢāļ°āđ€āļ—āļĻUnited States of America
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ22203
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ15713668850
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.priviahealth.com/
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™PRVA
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļApr 29, 2021
āļ‹āļĩāļ­āļĩāđ‚āļ­Mehrotra (Parth)

āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—āļ‚āļ­āļ‡ Privia Health Group Inc


āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
1.33M
+0.63%
Mr. Parth Mehrotra
Mr. Parth Mehrotra
Chief Executive Officer, Director
Chief Executive Officer, Director
416.15K
+35.61%
Mr. David Mountcastle, CPA
Mr. David Mountcastle, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
349.34K
+13.60%
Dr. Patricia Anne Maryland
Dr. Patricia Anne Maryland
Independent Director
Independent Director
31.19K
+26.92%
Dr. Jaewon Ryu, M.D.
Dr. Jaewon Ryu, M.D.
Independent Director
Independent Director
27.52K
+30.51%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Independent Director
Independent Director
7.67K
--
Mr. Shawn Morris, CPA
Mr. Shawn Morris, CPA
Director
Director
--
--
Ms. Nancy G. Cocozza
Ms. Nancy G. Cocozza
Independent Director
Independent Director
--
--
Mr. David King
Mr. David King
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Thomas A. (Tom) Mccarthy
Mr. Thomas A. (Tom) Mccarthy
Independent Director
Independent Director
--
--
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
1.33M
+0.63%
Mr. Parth Mehrotra
Mr. Parth Mehrotra
Chief Executive Officer, Director
Chief Executive Officer, Director
416.15K
+35.61%
Mr. David Mountcastle, CPA
Mr. David Mountcastle, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
349.34K
+13.60%
Dr. Patricia Anne Maryland
Dr. Patricia Anne Maryland
Independent Director
Independent Director
31.19K
+26.92%
Dr. Jaewon Ryu, M.D.
Dr. Jaewon Ryu, M.D.
Independent Director
Independent Director
27.52K
+30.51%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Independent Director
Independent Director
7.67K
--

āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰

āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
FFS-patient care
352.60M
60.75%
Capitated revenue
90.91M
15.66%
Shared savings
79.99M
13.78%
FFS-administrative services
33.62M
5.79%
Care management fees
20.99M
3.62%
Other revenue
2.31M
0.40%
āļ‚āđ‰āļ­āļĄāļđāļĨāļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡āļĒāļąāļ‡āđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļāļēāļĢāđ€āļ›āļīāļ”āđ€āļœāļĒāļˆāļēāļāļ—āļēāļ‡āļšāļĢāļīāļĐāļąāļ—
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
FFS-patient care
352.60M
60.75%
Capitated revenue
90.91M
15.66%
Shared savings
79.99M
13.78%
FFS-administrative services
33.62M
5.79%
Care management fees
20.99M
3.62%
Other revenue
2.31M
0.40%

āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™

āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 19 āļ.āļž.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 19 āļ.āļž.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
BlackRock Institutional Trust Company, N.A.
13.25%
Durable Capital Partners LP
9.77%
The Vanguard Group, Inc.
9.68%
Fidelity Management & Research Company LLC
8.63%
Rubicon Founders, LLC
4.67%
āļ­āļ·āđˆāļ™ āđ†
54.00%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
BlackRock Institutional Trust Company, N.A.
13.25%
Durable Capital Partners LP
9.77%
The Vanguard Group, Inc.
9.68%
Fidelity Management & Research Company LLC
8.63%
Rubicon Founders, LLC
4.67%
āļ­āļ·āđˆāļ™ āđ†
54.00%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
59.75%
Investment Advisor/Hedge Fund
20.12%
Hedge Fund
15.68%
Individual Investor
6.77%
Research Firm
1.69%
Pension Fund
1.42%
Bank and Trust
0.41%
Insurance Company
0.03%
Sovereign Wealth Fund
0.03%

āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 1 āļĄ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 1 āļĄ.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q4
531
121.21M
98.54%
-6.04M
2025Q3
514
121.30M
98.62%
-7.52M
2025Q2
517
129.73M
106.38%
-7.98M
2025Q1
530
136.71M
112.18%
-7.58M
2024Q4
523
135.99M
112.85%
-22.61M
2024Q3
533
137.04M
114.53%
-19.89M
2024Q2
535
137.24M
115.06%
-22.76M
2024Q1
525
138.01M
116.30%
-17.09M
2023Q4
500
129.42M
109.89%
-22.91M
2023Q3
486
123.27M
105.26%
-25.19M
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™


āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
BlackRock Institutional Trust Company, N.A.
16.43M
13.35%
+751.31K
+4.79%
Sep 30, 2025
Durable Capital Partners LP
11.69M
9.51%
+203.84K
+1.77%
Sep 30, 2025
The Vanguard Group, Inc.
12.08M
9.82%
+607.45K
+5.30%
Sep 30, 2025
Fidelity Management & Research Company LLC
11.00M
8.94%
-1.24M
-10.13%
Sep 30, 2025
Rubicon Founders, LLC
5.77M
4.69%
--
--
Sep 30, 2025
Boehler (Adam)
5.77M
4.69%
-505.00K
-8.04%
Oct 20, 2025
Riverbridge Partners, LLC
4.63M
3.77%
-314.00K
-6.35%
Sep 30, 2025
State Street Investment Management (US)
4.35M
3.54%
+182.15K
+4.37%
Sep 30, 2025
Van Berkom & Associates Inc.
3.77M
3.07%
+873.34K
+30.10%
Sep 30, 2025
Geode Capital Management, L.L.C.
2.78M
2.26%
+127.52K
+4.80%
Sep 30, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Innovator IBD Breakout Opportunities ETF
2.68%
Global X HealthTech ETF
2.53%
State Street SPDR S&P Health Care Services ETF
2.19%
Invesco S&P SmallCap Health Care ETF
1.72%
First Trust Nasdaq Lux Digi Health Solutions ETF
1%
Langar Global HealthTech ETF
0.78%
Harbor Human Capital Factor US Small Cap ETF
0.63%
First Trust Small Cap Growth AlphaDEX Fund
0.57%
iShares U.S. Healthcare Providers ETF
0.44%
WisdomTree US SmallCap Quality Growth Fund
0.35%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
Innovator IBD Breakout Opportunities ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.68%
Global X HealthTech ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.53%
State Street SPDR S&P Health Care Services ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.19%
Invesco S&P SmallCap Health Care ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.72%
First Trust Nasdaq Lux Digi Health Solutions ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1%
Langar Global HealthTech ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.78%
Harbor Human Capital Factor US Small Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.63%
First Trust Small Cap Growth AlphaDEX Fund
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.57%
iShares U.S. Healthcare Providers ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.44%
WisdomTree US SmallCap Quality Growth Fund
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.35%

āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ


āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 0.00 USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ

āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™


āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™